5a13be122b
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
5.2 KiB
5.2 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Controlled Substances - As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63. | Controlled Substances - As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63. | us/states/tn | Tennessee General Assembly | 110 | SB 2099 | Tennessee SB 2099 (110) |
|
|
enacted |
|
1 | 44 | 1 | 2018-01-29 | 2018-04-17 | openstates | ocd-bill/a597ae01-6e74-4979-a2bb-4c4193bf3e30 | http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB2099&GA=110 | 678fd77ff565081471bc6ef89a7ce4cece87e8ef7030502dc05041ee43e32804 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Tennessee SB 2099 (110) — Controlled Substances - As enacted, permits the direct administration of buprenorphine mono or buprenorphine without the use of naloxone as a treatment for substance use disorder under certain circumstances. - Amends TCA Title 53, Chapter 10; Title 53, Chapter 11 and Title 63.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Current Version (committee substitute) — source
Votes
- SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 8, Nays 0 PNV 0 3/7/2018 Passed (1) — 8–0 (pass) · upper
Sponsors
- Dickerson — primary (person)
- Terry — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2018-01-29 Filed for intro.
introduction, reading-1 - 2018-01-31 Filed for introduction
introduction, reading-1 - 2018-01-31 Intro., P1C.
introduction - 2018-02-01 Introduced, Passed on First Consideration
introduction - 2018-02-01 P2C, ref. to Health Committee
referral-committee - 2018-02-05 Passed on Second Consideration, refer to Senate Judiciary Committee
- 2018-02-05 Assigned to s/c Health Subcommittee
referral-committee - 2018-02-07 Placed on s/c cal Health Subcommittee for 2/14/2018
- 2018-02-14 Placed on s/c cal Health Subcommittee for 2/21/2018
- 2018-02-14 Action Def. in s/c Health Subcommittee to 2/21/2018
- 2018-02-21 Placed on cal. Health Committee for 2/27/2018
- 2018-02-21 Rec for pass if am by s/c ref. to Health Committee
referral-committee - 2018-02-26 Sponsor(s) Added.
- 2018-02-27 Rec. for pass. if am., ref. to Calendar & Rules Committee
committee-passage-favorable - 2018-02-28 Placed on Senate Health and Welfare Committee calendar for 3/7/2018
- 2018-02-28 Refer to Senate Health & Welfare Committee
- 2018-02-28 Recalled from Senate Judiciary Committee
- 2018-02-28 Placed on cal. Calendar & Rules Committee for 3/1/2018
- 2018-03-01 H. Placed on Regular Calendar for 3/5/2018
- 2018-03-05 Sponsor(s) Added.
- 2018-03-05 Passed H., as am., Ayes 96, Nays 0, PNV 0
passage - 2018-03-05 H. adopted am. (Amendment 1 - HA0730)
amendment-passage - 2018-03-06 Engrossed; ready for transmission to Sen.
- 2018-03-07 Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 8, Nays 0 PNV 0
- 2018-03-08 Received from House, Passed on First Consideration
introduction - 2018-03-20 Placed on Senate Regular Calendar calendar for 3/22/2018
- 2018-03-22 Sponsor(s) Added.
- 2018-03-22 Senate Reset on calendar for 3/29/2018
- 2018-03-27 Placed on Senate Regular Calendar calendar for 3/29/2018
- 2018-03-29 Placed on Senate Regular Calendar calendar for 4/2/2018
- 2018-03-29 Senate Reset on calendar 4/2/18
- 2018-04-02 Sponsor(s) Added.
- 2018-04-02 Companion House Bill substituted
- 2018-04-02 Passed Senate, Ayes 33, Nays 0
passage - 2018-04-02 Amendment withdrawn. (Amendment 1 - SA0724)
- 2018-04-02 Senate substituted House Bill for companion Senate Bill.
- 2018-04-03 Enrolled; ready for sig. of H. Speaker.
- 2018-04-04 Signed by H. Speaker
- 2018-04-05 Signed by Senate Speaker
- 2018-04-06 Transmitted to Governor for his action.
executive-receipt - 2018-04-12 Signed by Governor.
executive-signature - 2018-04-17 Comp. became Pub. Ch. 674
- 2018-04-17 Pub. Ch. 674
- 2018-04-17 Effective date(s) 04/12/2018
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/a597ae01-6e74-4979-a2bb-4c4193bf3e30. Confidence: reported (aggregated from official Tennessee legislature records).